Muramic Acid in Peripheral Blood Leukocytes of Healthy Human Subjects

1. Waage A, Halstensen A, Espevik T. Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet 1987;1:355-7. 2. Girardin E, Grau GE, Dayer JM, Roux-Lombard P, J5 Study Group, Lambert PH. Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura. N Engl J Med 1988;319:397-400. 3. Michie HR, Manogue KR, Spriggs DR, et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 1988;318:1481-6. 4. Andersen BM, Solberg O, Bryn K, et al. Endotoxin liberation from Neisseria meningitidis isolated from carriers and clinical cases. Scand J Infect Dis 1987;19:409-19. 5. Jones DM, Borrow R, Fox AJ, Gray S, Cartwright KA, Poolman JT. The lipopolysaccharide immunotype as a virulence determinant in Neisseria meningitidis. Microb Pathog 1992;13:219-24. 6. Desch CE, Kovach NL, Present W, Broyles C, Harlan JM. Production of human tumor necrosis factor from whole blood ex vivo. Lymphokine Res 1989;8:141-6. 7. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor a: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 1990;87:1233-7. 10.